Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

During the Trading Day
60.98 +0.48 / +0.79%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
61.00 +0.02 / +0.03%
 
Volume: 205.0K

Today’s Trading

Previous close60.50
Today’s open61.56
Day’s range60.28 - 61.60
Volume12,031,729
Average volume (3 months)9,253,881
Market cap$100.1B
Dividend yield3.35%
Data as of 4:00pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)-57.03%
Earnings growth (this year)+28.25%
Earnings growth (next 5 years)+14.10%
Revenue growth (last year)+6.23%
P/E ratio47.3
Price/Sales5.28
Price/Book55.27

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+1.41+2.42%
GSKGlaxoSmithKline+1.17+2.96%
NVONovo Nordisk+1.15+2.12%
CELGCelgene+4.12+3.57%
Data as of 4:02pm ET, 09/02/2015

Financials

Next reporting dateOctober 30, 2015
EPS forecast (this quarter)$1.06
Annual revenue (last year)$20.0B
Annual profit (last year)$1.8B
Net profit margin8.89%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts

Partner Offers